Twenty Percent Of Surveyed Cancer Patients Report Using Cannabis

This article was originally published on Cannabis & Tech Today, and appears here with permission.

According to the World Health Organization cancer is the second leading cause of death worldwide.

It is estimated that as many as 1 out of every 6 deaths worldwide are caused by cancer.

Roughly 22% of cancer deaths were the result of tobacco use, with obesity, a lack of sufficient fruit and vegetable consumption, lack of exercise, and excessive alcohol use also being major contributors to developing cancer.

Anyone that has battled cancer or have a loved one that did will be quick to tell you that it is absolutely horrific.

It’s easily one of the saddest things someone can endure.

A growing number of cancer patients are turning to medical cannabis to supplement their cancer treatment regimens according to a recent study.

Medical Cannabis Use Among Cancer Patients

A team of researchers at Beaumont Hospital, Office of Hematology and Oncology recently surveyed cancer patients to gauge what percentage of them used medical cannabis.

The survey involved 188 cancer patients, some of which reported as being registered medical cannabis (MC) patients and others not. 

The survey was initially sent to 327 patients, with 188 of the surveys being returned.

Participants provided their answers back in 2018, however, the results of the survey and analysis of the survey results were not released until recently.

“A median composite baseline symptom score ranging from 8 (best) to 32 (worst) was higher in patients using MC versus nonusers; 17.5 versus 14.4 (P<0.001). Pain was the symptom with the highest frequency of improvement 34/42 (81%), followed by appetite 34/44 (77.3%), and anxiety 32/44 (73%). MC improved the ability to tolerate treatment in 24/44 (54.5%),” the study’s authors stated.

“This survey adds to the growing body of evidence that MC is a safe and potentially effective adjunct to conventional medications for the palliation of cancer patients. … Given the increasing prevalence of MC use among cancer patients, it is imperative that hematologist and oncologists become comfortable with discussing this topic with patients,” the authors concluded.

Be Mindful When Recommending Medical Cannabis

Cancer patients are going through the hardest part of their life, and that’s something that loved ones need to always keep in mind.

For many cancer patients, they are literally facing possible death, and as such, any recommended treatments need to be offered up in a thoughtful manner.

Several peer-reviewed studies have found cannabis to be an effective treatment for cancer, however, there still needs to be further research conducted.

Telling a cancer patient that ‘cannabis will cure their cancer’ is a cruel thing to do because it may give them false hope.

Instead, respectfully suggest that they consider using cannabis and offer to assist them in their research to help them decide whether cannabis is right for their situation or not.

Read the original Article on Cannabis & Tech Today

Benzinga's Related Links: 

Posted In: CannabisHealth CareMarketsGeneralcancercannabis & tech todayPatients
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...